Vaccinex, Inc. Additional Paid in Capital, Common Stock
Vaccinex, Inc. (VCNX) had Additional Paid in Capital, Common Stock of $354.42 million as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2025-04-15
- 2024-12-31: Additional Paid in Capital, Common Stock $354.42M.
- 2024-09-30: Additional Paid in Capital, Common Stock $352.35M.
- 2024-06-30: Additional Paid in Capital, Common Stock $345.22M.
- 2024-03-31: Additional Paid in Capital, Common Stock $345.25M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2024-12-31 | $354.42M 10-K · filed 2025-04-15 | |
| 2024-09-30 | $352.35M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $345.22M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $345.25M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $337.63M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $332.75M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $331.28M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $327.04M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $324.88M 10-K/A · filed 2024-04-25 | $324.88M 10-K · filed 2023-03-31 |
| 2022-09-30 | $320.92M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $320.79M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $320.65M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $307.28M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $307.13M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $306.97M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $284.88M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $250.91M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $250.84M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $232.75M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $230.09M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $222.40M 10-K · filed 2021-03-31 |